Fimea
Federal · Finland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Helsinki, FinlandPhone Number
+358 295223341Website
www.fimea.fiRevenue
$56.2 MillionIndustry
About Fimea
Is Fimea your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Fimea had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Fimea
Product Launch: Get notified when Fimea launches new products
Fimea, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Fimea has recently received funding, and reach out quickly before it becomes old news!
Check out if Fimea is spiking on competitors!
Earning: See what the market has to say on Fimea recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Fimea has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Fimea is experiencing very low activity levels compared to other companies in the Government sector.
What does this means?
Fimea is drawing exceptional interest within the Government industry, suggesting notable developments or strong market momentum, learn more about Fimea.
Fimea Tech Stack
A closer look at the technologies used by Fimea
Fimea News & Media
Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies
Faron Pharmaceuticals Ltd. (“Faron” or “Company”) Faron Announces US Food and Drug Administration and Finnish Medicines Agency Approval to Initiate Phase I/II Bexmarilimab Combination Study in Hematologic Malignancies · Phase 1 dose escalation study will evaluate the safety and tolerability of combination therapy and determine the recommended dose for Phase 2 expansion · Patient recruitment will commence in the coming weeks · Supporting pre-clinical bexmarilimab hematology data was presented at
Top Federal Companies
Frequently Asked Questions Regarding Fimea
Fimea is the Finnish Medicines Agency responsible for ensuring the safety and efficacy of medicines and medical devices. It provides services such as drug safety monitoring, clinical trial oversight, and the evaluation of healthcare technologies. Fimea collaborates with healthcare professionals, patients, and pharmaceutical companies to enhance med... Read More